- Home
- BZUN vs BDTX Comparison
BZUN vs BDTX Comparison
Compare BZUN & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BZUN | BDTX |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.9M | 148.1M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BZUN | BDTX |
|---|---|---|
| Price | $2.91 | $2.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.40 |
| AVG Volume (30 Days) | 281.4K | ★ 938.7K |
| Earning Date | 03-19-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | ★ $1,372,022,139.00 | $70,000,000.00 |
| Revenue This Year | $6.04 | N/A |
| Revenue Next Year | $3.99 | N/A |
| P/E Ratio | ★ N/A | $6.80 |
| Revenue Growth | ★ 6.08 | N/A |
| 52 Week Low | $2.12 | $1.20 |
| 52 Week High | $4.88 | $4.94 |
Technical Indicators
Market Signals| Indicator | BZUN | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 44.18 |
| Support Level | $2.74 | $2.49 |
| Resistance Level | $2.95 | $2.70 |
| Average True Range (ATR) | 0.13 | 0.15 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 30.61 | 41.35 |
Price Performance
Historical ComparisonAbout BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.